Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 462

1.

Advocacy for children with epilepsy: Leveraging the WHA resolution. Advocacy Task Force, Commission of Pediatrics, International League Against Epilepsy.

Wilmshurst JM, Guekht A, Secco M, Helen Cross J, Perucca E; Advocacy Task Force, Commission of Pediatrics, International League Against Epilepsy.

Epilepsia Open. 2018 May 14;3(2):167-174. doi: 10.1002/epi4.12220. eCollection 2018 Jun. Review.

2.

No proof of a causal relationship between antiepileptic drug treatment and incidence of dementia. Comment on: Use of antiepileptic drugs and dementia risk-An analysis of Finnish health register and German health insurance data.

Helmstaedter C, Beghi E, Elger CE, Kälviäinen R, Malmgren K, May TW, Perucca E, Trinka E, Witt JA.

Epilepsia. 2018 May 28. doi: 10.1111/epi.14432. [Epub ahead of print] No abstract available.

PMID:
29806877
3.

Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.

Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F; EURAP Study Group.

Lancet Neurol. 2018 Jun;17(6):530-538. doi: 10.1016/S1474-4422(18)30107-8. Epub 2018 Apr 18.

PMID:
29680205
4.

Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307.

Krauss GL, Perucca E, Kwan P, Ben-Menachem E, Wang XF, Shih JJ, Patten A, Yang H, Williams B, Laurenza A.

Epilepsia. 2018 Apr;59(4):866-876. doi: 10.1111/epi.14044. Epub 2018 Mar 25.

PMID:
29574701
5.

Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?

Perucca E.

J Epilepsy Res. 2017 Dec 31;7(2):61-76. doi: 10.14581/jer.17012. eCollection 2017 Dec. Review.

6.

Genetic testing to prevent adverse reactions to antiepileptic drugs: Primum non nocere.

Guerrini R, Perucca E.

Neurology. 2018 Jan 23;90(4):155-156. doi: 10.1212/WNL.0000000000004869. Epub 2017 Dec 29. No abstract available.

PMID:
29288230
7.

A simple and rapid HPLC-UV method for the determination of retigabine in human plasma.

Franco V, Baruffi K, Gatti G, Marchiselli R, Fattore C, Canevini MP, Crema F, Perucca E.

Biomed Chromatogr. 2018 May;32(5):e4168. doi: 10.1002/bmc.4168. Epub 2018 Jan 24.

PMID:
29235121
8.

Maternal and fetal outcomes associated with vagus nerve stimulation during pregnancy.

Sabers A, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Thomas SV, Tomson T, Vajda F.

Epilepsy Res. 2017 Nov;137:159-162. doi: 10.1016/j.eplepsyres.2017.05.013.

PMID:
29054513
9.

Midazolam vs diazepam in prolonged seizures in children: A pharmacoeconomic approach.

Beghi E, Capovilla G, Franzoni E, Minicucci F, Romeo A, Verrotti A, Vigevano F, Perucca E.

Acta Neurol Scand. 2018 Jan;137(1):24-28. doi: 10.1111/ane.12814. Epub 2017 Sep 6.

PMID:
28875555
10.

How long for epilepsy remission in the ILAE definition?

Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, Engel J Jr, Forsgren L, French JA, Hesdorffer DC, Lee BI, Mathern GW, Moshe SL, Perucca E, Scheffer IE, Tomson T, Watanabe M, Wiebe S.

Epilepsia. 2017 Aug;58(8):1486-1487. doi: 10.1111/epi.13821. No abstract available.

PMID:
28799662
11.

Heterogeneous contribution of microdeletions in the development of common generalised and focal epilepsies.

Pérez-Palma E, Helbig I, Klein KM, Anttila V, Horn H, Reinthaler EM, Gormley P, Ganna A, Byrnes A, Pernhorst K, Toliat MR, Saarentaus E, Howrigan DP, Hoffman P, Miquel JF, De Ferrari GV, Nürnberg P, Lerche H, Zimprich F, Neubauer BA, Becker AJ, Rosenow F, Perucca E, Zara F, Weber YG, Lal D.

J Med Genet. 2017 Sep;54(9):598-606. doi: 10.1136/jmedgenet-2016-104495. Epub 2017 Jul 29.

12.

ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology.

Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Moshé SL, Nordli DR, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM.

Epilepsia. 2017 Apr;58(4):512-521. doi: 10.1111/epi.13709. Epub 2017 Mar 8.

13.

A new classification is born.

Zuberi SM, Perucca E.

Epilepsia. 2017 Apr;58(4):511. doi: 10.1111/epi.13694. Epub 2017 Mar 8. No abstract available.

14.

Seizure detection and neuromodulation: A summary of data presented at the XIII conference on new antiepileptic drug and devices (EILAT XIII).

Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS, Koepp MJ.

Epilepsy Res. 2017 Feb;130:27-36. doi: 10.1016/j.eplepsyres.2017.01.004. Epub 2017 Jan 16.

PMID:
28113141
15.

Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII).

Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS.

Epilepsia. 2017 Feb;58(2):181-221. doi: 10.1111/epi.13634. Epub 2017 Jan 23. Review.

16.

Perampanel effects in the WAG/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behavior.

Citraro R, Leo A, Franco V, Marchiselli R, Perucca E, De Sarro G, Russo E.

Epilepsia. 2017 Feb;58(2):231-238. doi: 10.1111/epi.13629. Epub 2016 Dec 18.

17.

Development and Validation of an HPLC-UV Assay for the Therapeutic Monitoring of the New Antiepileptic Drug Perampanel in Human Plasma.

Franco V, Marchiselli R, Fattore C, Tartara E, De Sarro G, Russo E, Perucca E.

Ther Drug Monit. 2016 Dec;38(6):744-750.

PMID:
27753779
18.

A Tribute to Steve White.

Perucca E.

Neurochem Res. 2017 Jul;42(7):1867-1868. doi: 10.1007/s11064-016-2071-1. Epub 2016 Oct 1. No abstract available.

PMID:
27696118
19.

Not all that glitters is gold: A guide to the critical interpretation of drug trials in epilepsy.

Perucca E, Wiebe S.

Epilepsia Open. 2016 Jul 27;1(1-2):9-21. doi: 10.1002/epi4.3. eCollection 2016 Sep. Review.

20.

Classification of the epilepsies: New concepts for discussion and debate-Special report of the ILAE Classification Task Force of the Commission for Classification and Terminology.

Scheffer IE, French J, Hirsch E, Jain S, Mathern GW, Moshé SL, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM.

Epilepsia Open. 2016 Jul 21;1(1-2):37-44. doi: 10.1002/epi4.5. eCollection 2016 Sep.

21.

Commentary: Message from the ILAE president.

Perucca E.

Epilepsia Open. 2016 Jul 21;1(1-2):8. doi: 10.1002/epi4.6. eCollection 2016 Sep. No abstract available.

22.

Withdrawal of valproic acid treatment during pregnancy and seizure outcome: Observations from EURAP.

Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F; EURAP Study Group.

Epilepsia. 2016 Aug;57(8):e173-7. doi: 10.1111/epi.13437. Epub 2016 Jun 20.

23.

Reflections on monotherapy trials for epilepsy - Authors' reply.

French JA, Mintzer S, Perucca E, Blum DE, Cramer JA, Messenheimer JA, Baulac M.

Lancet Neurol. 2016 Jun;15(7):657-658. doi: 10.1016/S1474-4422(16)00119-8. Epub 2016 May 9. No abstract available.

PMID:
27302226
24.

An investigation of the influence of patient-related factors and comedications on lamotrigine clearance in patients with epilepsy.

Baldoni AO, Freitas-Lima P, de Santi Ferreira FI, Martinez EZ, Queiroz RH, Sakamoto AC, Alexandre V, Perucca E, Pereira LR.

Clin Exp Pharmacol Physiol. 2016 Jul;43(7):685-9. doi: 10.1111/1440-1681.12584.

PMID:
27120710
25.

The safety of generic substitution in epilepsy.

Perucca E.

Lancet Neurol. 2016 Apr;15(4):344-5. doi: 10.1016/S1474-4422(16)00042-9. Epub 2016 Feb 12. No abstract available.

PMID:
26875742
26.

The remarkable story of valproic acid.

Tomson T, Battino D, Perucca E.

Lancet Neurol. 2016 Feb;15(2):141. doi: 10.1016/S1474-4422(15)00398-1. Epub 2016 Jan 12. No abstract available.

PMID:
28463122
27.

In Memoriam: Hanneke De Boer (1946-2015).

Reynolds ET, Covanis A, Perucca E.

Epilepsia. 2016 Jan;57(1):162-3. doi: 10.1111/epi.13293. No abstract available.

28.

Epilepsy, seizures, physical exercise, and sports: A report from the ILAE Task Force on Sports and Epilepsy.

Capovilla G, Kaufman KR, Perucca E, Moshé SL, Arida RM.

Epilepsia. 2016 Jan;57(1):6-12. doi: 10.1111/epi.13261. Epub 2015 Dec 10.

29.

The current state of epilepsy guidelines: A systematic review.

Sauro KM, Wiebe S, Dunkley C, Janszky J, Kumlien E, Moshé S, Nakasato N, Pedley TA, Perucca E, Senties H, Thomas SV, Wang Y, Wilmshurst J, Jetté N.

Epilepsia. 2016 Jan;57(1):13-23. doi: 10.1111/epi.13273. Epub 2015 Dec 10. Review.

30.

Antiepileptic drug use and epileptic seizures in nursing home residents in the Province of Pavia, Italy: A reappraisal 12 years after a first survey.

Galimberti CA, Tartara E, Dispenza S, Marchese D, Bonizzoni E, Perucca E; Elderly Nursing home Epilepsy Assessment—Pavia Study Group.

Epilepsy Res. 2016 Jan;119:41-8. doi: 10.1016/j.eplepsyres.2015.11.009. Epub 2015 Dec 1.

PMID:
26656178
31.

Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug.

Tomson T, Battino D, Perucca E.

Lancet Neurol. 2016 Feb;15(2):210-218. doi: 10.1016/S1474-4422(15)00314-2. Epub 2015 Dec 5. Review.

PMID:
26655849
32.

Challenges in the clinical development of new antiepileptic drugs.

Franco V, French JA, Perucca E.

Pharmacol Res. 2016 Jan;103:95-104. doi: 10.1016/j.phrs.2015.11.007. Epub 2015 Dec 2. Review.

PMID:
26611249
33.

Is a separate monotherapy indication warranted for antiepileptic drugs?

Mintzer S, French JA, Perucca E, Cramer JA, Messenheimer JA, Blum DE, Rogawski MA, Baulac M.

Lancet Neurol. 2015 Dec;14(12):1229-40. doi: 10.1016/S1474-4422(15)00229-X. Review.

PMID:
26581972
34.

Developing clinical practice guidelines for epilepsy: A report from the ILAE Epilepsy Guidelines Working Group.

Sauro KM, Wiebe S, Perucca E, French J, Dunkley C, de Marinis A, Kirkpatrick M, Jetté N.

Epilepsia. 2015 Dec;56(12):1859-69. doi: 10.1111/epi.13217. Epub 2015 Oct 30.

35.

Availability of antiepileptic drugs across Europe.

Baftiu A, Johannessen Landmark C, Nikaj V, Neslein IL, Johannessen SI, Perucca E.

Epilepsia. 2015 Dec;56(12):e191-7. doi: 10.1111/epi.13210. Epub 2015 Oct 19.

36.

Epilepsy priorities in Europe: A report of the ILAE-IBE Epilepsy Advocacy Europe Task Force.

Baulac M, de Boer H, Elger C, Glynn M, Kälviäinen R, Little A, Mifsud J, Perucca E, Pitkänen A, Ryvlin P.

Epilepsia. 2015 Nov;56(11):1687-95. doi: 10.1111/epi.13201. Epub 2015 Sep 28. Review.

37.

From global campaign to global commitment: The World Health Assembly's Resolution on epilepsy.

Covanis A, Guekht A, Li S, Secco M, Shakir R, Perucca E.

Epilepsia. 2015 Nov;56(11):1651-7. doi: 10.1111/epi.13192. Epub 2015 Sep 22. Review.

38.

The pharmacogenomics of epilepsy.

Franco V, Perucca E.

Expert Rev Neurother. 2015 Oct;15(10):1161-70. doi: 10.1586/14737175.2015.1083424. Epub 2015 Sep 1. Review.

PMID:
26327193
39.

Antiepileptic drugs and intrauterine death: A prospective observational study from EURAP.

Tomson T, Battino D, Bonizzoni E, Craig JJ, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F; EURAP Study Group.

Neurology. 2015 Aug 18;85(7):580-8. doi: 10.1212/WNL.0000000000001840. Epub 2015 Jul 17.

PMID:
26187231
40.

Extending the phenotypic spectrum of RBFOX1 deletions: Sporadic focal epilepsy.

Lal D, Pernhorst K, Klein KM, Reif P, Tozzi R, Toliat MR, Winterer G, Neubauer B, Nürnberg P, Rosenow F, Becker F, Lerche H, Kunz WS, Kurki MI, Hoffmann P, Becker AJ, Perucca E, Zara F, Sander T, Weber YG.

Epilepsia. 2015 Sep;56(9):e129-33. doi: 10.1111/epi.13076. Epub 2015 Jul 15.

41.

Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.

Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F; EURAP Study Group.

Neurology. 2015 Sep 8;85(10):866-72. doi: 10.1212/WNL.0000000000001772. Epub 2015 Jun 17.

PMID:
26085607
42.

A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy.

Luoni C, Canevini MP, Capovilla G, De Sarro G, Galimberti CA, Gatti G, Guerrini R, La Neve A, Mazzucchelli I, Rosati E, Specchio LM, Striano S, Tinuper P, Perucca E.

Epilepsia. 2015 Jul;56(7):1162-73. doi: 10.1111/epi.13030. Epub 2015 Jun 4.

43.

CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.

Franco V, Perucca E.

Expert Opin Drug Metab Toxicol. 2015;11(8):1269-79. doi: 10.1517/17425255.2015.1053463. Epub 2015 Jun 3. Review.

PMID:
26037375
44.

Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII).

Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS.

Epilepsy Res. 2015 Mar;111:85-141. doi: 10.1016/j.eplepsyres.2015.01.001. Epub 2015 Jan 19. Review.

PMID:
25769377
45.

Sertraline-induced potentiation of the CYP3A4-dependent neurotoxicity of carbamazepine: an in vitro study.

Ghosh C, Hossain M, Spriggs A, Ghosh A, Grant GA, Marchi N, Perucca E, Janigro D.

Epilepsia. 2015 Mar;56(3):439-49. doi: 10.1111/epi.12923. Epub 2015 Feb 5.

46.

Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs.

Zaccara G, Perucca E.

Epileptic Disord. 2014 Dec;16(4):409-31. doi: 10.1684/epd.2014.0714. Review.

47.

Commentary: why an international epilepsy day?

Perucca E.

Epilepsia. 2015 Feb;56(2):170-1. doi: 10.1111/epi.12813. Epub 2014 Nov 17. No abstract available.

48.

Epilepsy: new advances.

Moshé SL, Perucca E, Ryvlin P, Tomson T.

Lancet. 2015 Mar 7;385(9971):884-98. doi: 10.1016/S0140-6736(14)60456-6. Epub 2014 Sep 24.

PMID:
25260236
49.

Commentary: Epilepsy is a Global Problem.

Perucca E, Covanis A, Dua T.

Epilepsia. 2014 Sep;55(9):1326-8. doi: 10.1111/epi.12725. Epub 2014 Aug 4. No abstract available.

50.

Off-label prescribing of antiepileptic drugs in pharmacoresistant epilepsy: a cross-sectional drug utilization study of tertiary care centers in Italy.

Franco V, Canevini MP, Capovilla G, De Sarro G, Galimberti CA, Gatti G, Guerrini R, La Neve A, Rosati E, Specchio LM, Striano S, Tinuper P, Perucca E.

CNS Drugs. 2014 Oct;28(10):939-49. doi: 10.1007/s40263-014-0189-8.

PMID:
25056568

Supplemental Content

Loading ...
Support Center